We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Implantable Micropacemaker Treats Fetal Heart Block

By HospiMedica International staff writers
Posted on 22 Apr 2015
A new study describes the first fully implantable micropacemaker designed for dealing with potentially fatal fetal heart block.

Developed by researchers at Children’s Hospital Los Angeles (CHLA; CA, USA) and the University of Southern California (USC; Los Angeles, USA), the miniature pacemaker creates the potential to prevent miscarriages and premature births for those afflicted with fetal heart block, potentially without causing harm to the fetus or to the mother. More...
The micropacemaker, which has already undergone pre-clinical testing, has been designated a humanitarian use device exemption by the US Food and Drug Administration (FDA). The investigators anticipate first human use of the device in the near future.

Although congenital heart block can be diagnosed in utero, all attempts to treat the condition with a standard pacemaker have so far failed, since the size of an adult pacemaker requires that only a small portion be implanted in the fetus, while the electronics remain externalized. This design has uniformly failed, likely due to fetal movement causing the electrodes to become dislodged from the heart. The study describing the fetal micropacemaker was published in the March 2015 issue of Heart Rhythm.

“Up until now, the pacemaker devices that have been used in an attempt to treat this condition in a fetus were designed for adults,” said lead author pediatric cardiologist Yaniv Bar-Cohen, MD, of CHLA. “We have lacked an effective treatment option for fetuses.”

“Building on our experience of using microfabrication techniques to create biomedical devices, we have developed a micropacemaker small enough to reside entirely within the fetus,” said study coauthor Gerald Loeb, MD, a professor of biomedical engineering at the Viterbi School of Engineering at USC. “This will allow the fetus to move freely without risk of dislodging the electrodes.”

Congenital heart block is a defect of the heart’s electrical system that originates in the developing fetus. Within the right atrium of a normal heart is a natural pacemaker that sends an electrical stimulus travels from the pacemaker (SA node) to the ventricles (AV node). If the transmission of the signal is impeded (heart block or an AV block), the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed. If the heart block occurs in the fetus or newborn, the condition is known as congenital heart block.

Related Links:

Children’s Hospital Los Angeles
University of Southern California



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Lead study author Ramy Ghanim (left) and co-author Joy Jackson test an small implantable device alongside Assistant Professor Alex Abramson. In a new Science paper, they describe a networking system that connects therapeutic implants and wearable devices by using the body’s natural conductivity to send tiny signals. (Photo courtest of Georgia Tech)

Bioelectronic Network Enables Devices to Communicate Through Body Tissue and Coordinate Therapy

Wearable sensors and implanted therapeutic devices can be difficult to coordinate when signals must pass through the body. Conventional wireless signals do not travel well through tissue, while the antennas... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.